181 related articles for article (PubMed ID: 16672771)
1. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
6. Modulation of bevacizumab-induced toxicity for cultured human corneal fibroblasts.
Kim EK; Kang SW; Kim JY; Min K; Kim TI
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3922-31. PubMed ID: 23640039
[TBL] [Abstract][Full Text] [Related]
7. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
Lee HS; Chung SK
Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
[TBL] [Abstract][Full Text] [Related]
8. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
Azar DT
Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro.
Yan L; Wu W; Wang Z; Li C; Lu X; Duan H; Zhou J; Wang X; Wan P; Song Y; Tang J; Han Y
Ophthalmic Res; 2013; 49(3):150-60. PubMed ID: 23258255
[TBL] [Abstract][Full Text] [Related]
10. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
[TBL] [Abstract][Full Text] [Related]
11. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
Kaur G; Belotti D; Burger AM; Fisher-Nielson K; Borsotti P; Riccardi E; Thillainathan J; Hollingshead M; Sausville EA; Giavazzi R
Clin Cancer Res; 2004 Jul; 10(14):4813-21. PubMed ID: 15269157
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
14. Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells.
Wang YS; Eichler W; Friedrichs U; Yafai Y; Hoffmann S; Yasukawa T; Hui YN; Wiedemann P
Curr Eye Res; 2005 Jun; 30(6):479-89. PubMed ID: 16020281
[TBL] [Abstract][Full Text] [Related]
15. A model of angiogenesis in the mouse cornea.
Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
[TBL] [Abstract][Full Text] [Related]
16. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.
Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
